Isra University   Report issue

Academic/Hospital Phase 2
Founded: Hyderabad Pakistan (1997)

Organization Overview

First Clinical Trial
2015
NCT03664375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Isra University | Isra University islamabad | Isra University Islamabad Campus | Isra University, Jordan | Salameh Aldaja

Active Ingredients

Drugs in Phase 2 Trials (1)

glucose (1 trial)

Drugs in Other Trials (4)

chondroitin (1 trial)

creatine (1 trial)

glucosamine (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes, Gestational (Phase 2)

Hyperglycemia (Phase 2)

Pregnancy in Diabetics (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5